Trial Profile
Levooxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2013
Price :
$35
*
At a glance
- Drugs Bismuth (Primary) ; Levofloxacin (Primary) ; Amoxicillin; Metronidazole; Proton pump inhibitors; Tetracycline
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2013 New trial record